Skip to main content

Steroids in Spinal Cord Injury

 The use of steroids, particularly high-dose methylprednisolone (MP), in the treatment of acute spinal cord injury (SCI) has been extensively studied and remains a topic of debate. The primary goal of administering steroids post-injury is to mitigate secondary damage by reducing inflammation and oxidative stress. However, the efficacy and safety of this approach have been questioned.



Key Clinical Trials and Findings:

  1. National Acute Spinal Cord Injury Study (NASCIS) II (1990): This randomized controlled trial evaluated the effects of high-dose MP administered within 8 hours of injury. A subgroup analysis suggested a modest improvement in motor function scores for patients treated within this time frame. However, the clinical significance of this improvement has been debated, and concerns about methodological limitations were raised.

    TheNNT

  2. NASCIS III (1997): This study compared 24-hour and 48-hour MP infusion protocols. The results did not demonstrate a significant benefit in neurological outcomes with extended MP administration. Additionally, there was an observed increase in severe pneumonia cases in the 48-hour MP group, raising concerns about potential harms associated with prolonged steroid use.

    TheNNT

  3. Cochrane Review (2012): An updated systematic review concluded that high-dose MP administered within 8 hours of acute SCI resulted in a small improvement in motor function. However, the review also highlighted the lack of significant long-term benefits and the increased risk of complications, leading to a recommendation against the routine use of MP in acute SCI.

    Welcome

  4. TheNNT.com Analysis: A review of multiple trials indicated no clear benefit of steroid use in acute SCI and noted an increased incidence of complications such as infections and gastrointestinal issues. The analysis concluded that the potential harms of high-dose MP likely outweigh any benefits, advising against its routine use.

    TheNNT

Current Clinical Recommendations:

Based on the available evidence, several professional organizations, including the Congress of Neurological Surgeons and the American Association of Neurological Surgeons, recommend against the routine use of high-dose MP in the treatment of acute SCI due to the lack of definitive benefit and the potential for significant adverse effects.

TheNNT

Conclusion:

While early studies suggested a potential role for high-dose steroids in improving outcomes following acute spinal cord injury, subsequent analyses and reviews have not demonstrated consistent or clinically significant benefits. Moreover, the increased risk of serious complications associated with steroid use has led to a consensus against their routine administration in this context. Clinicians are advised to consider alternative therapeutic strategies and to focus on supportive care measures that have a more established efficacy and safety profile.

The latest ATLS 10th edition Guidelines say there is insufficient data to recommend for or against the usage of steroids in acute spinal trauma.

Comments

Post a Comment

Popular posts from this blog

CRASH-3 TRIAL (Tranexamic Acid in Head Injury)

 
Post a Comment
Read more

BLUNT TRAUMA TO EYE VARIOUS FINDINGS

Blunt trauma to the eye can result in a wide range of findings and injuries, depending on the force and direction of the impact. The Trauma can be due to Direct Injury Contre-coup Injury Shearing forces and shock waves. The eye is a delicate organ with several components, and trauma can result into open or closed globe injuries. Following are some of the findings and injuries commonly associated with blunt trauma to different components of the eye:         Eyelids and Surrounding Tissues: ü   Contusions and bruising of the eyelids and periorbital area. May give an appearance of Raccoon Eyes. ü   Lacerations or cuts on the eyelids. ü   Swelling and edema of the eyelids.         Conjunctiva: ü   Subconjunctival hemorrhage, which appears as redness on the white part of the eye. ü   Chemosis, which is swelling of the conjunctiva.         Cornea: ü ...
Post a Comment
Read more

SALSA Trial

The "Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia:  The SALSA Randomized Clinical Trial" published in JAMA, is a significant clinical trial that specifically investigated the use of slow continuous infusion therapies of hypertonic saline with fast bolus replacement, for patients with symptomatic hyponatremia.  Background:   Symptomatic hyponatremia is a condition in which patients have low sodium levels in the blood, leading to neurological symptoms and potentially life-threatening complications. Rapid correction of sodium levels is necessary in such cases to alleviate symptoms and prevent harm. Objective:   The SALSA trial aimed to assess the efficacy and safety of two different strategies for correcting symptomatic hyponatremia using hypertonic saline solutions.  Methods: The study was a randomized clinical trial involving patients with symptomatic hyponatremia. Participants were divided into two groups:...
Post a Comment
Read more